TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
12/02/2025
Back to search
Official data from USPTO
INTO ACCELERATING INHALATION DEVELOPMENT
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
33
Latest update
12/04/2025
Trademark type
Combined
Nice classes
1, 5, 42
Filing date
11/21/2022
Registration date
06/18/2024
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
06/18/2024
Last transaction
12/04/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
3
Owner type
99
Owner location
IT
Examiner
BERNS,LEE ANNE
Law office
M90
Current location
FILE REPOSITORY (FRANCONIA)
Mark description
The mark consists of the stylized letter "i" with the word "INTO" in large letters situated to the right of "i" and "accelerating inhalation development" in lower case letters situated below "INTO".
Holders and representatives
Holders
STERLING S.P.A.
DFE Pharma GmbH & Co. KG
Harro Höfliger Verpackungsmaschinen GmbH
Representatives
Michael N. Mercanti Lucas & Mercanti, LLP
Technical classification
Nice Classes
Class 1Class 5Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Chemicalschemical additives and chemical compositionsactive chemical ingredients and excipients for use in the manufacture of pharmaceuticals for treating respiratory diseases; chemical substances for analyses in laboratoriesother than for medical or veterinary purposesuse in the manufacture of pharmaceuticals
Class 5
Pharmaceuticalspharmaceutical preparationspharmaceuticals for medical or veterinary purposespharmaceutical compositionsvaccines and medicine being pharmaceutical preparationsall for use in the treatment of respiratory diseases
Class 42
Pharmaceutical and chemical research services; pharmaceutical and chemical product development services for others; pharmaceutical and chemical design services being pharmaceutical and chemical product development services for others; testing of pharmaceuticals and chemicals; medical and scientific researchconducting clinical trials of pharmaceuticals for others and testing of chemicals; pharmaceutical and chemical analysis; laboratory research services relating to orally inhaled and nasal drugs products; pharmaceutical and chemical product evaluation; preparation of reports in the nature of technical writing relating to the aforesaid pharmaceutical and chemical research; inspection being testing and inspection of pharmaceuticals and chemicals; scientific and technological servicesscientific researchformulation developmentanalysis and testing in the field of orally inhaled and nasal drugs products; biological research services; quality control for others and authentication services for pharmaceuticals; informationadvice and consultancy services in relation to the aforesaid services
Publications
History of USPTO decisions and trademark events.
33 publications found
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
12/02/2025
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
12/02/2025
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
12/02/2025
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
02/22/2025
XXSS
GENERIC MADRID TRANSACTION SENT TO IB
11/27/2024
XXCR
GENERIC MADRID TRANSACTION CREATED
11/27/2024
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
09/18/2024
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
06/18/2024
R.PR
REGISTERED-PRINCIPAL REGISTER
06/18/2024
GPNX
NOTIFICATION PROCESSED BY IB
04/16/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
04/02/2024
PUBO
PUBLISHED FOR OPPOSITION
04/02/2024
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
03/27/2024
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
03/27/2024
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
03/13/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
02/23/2024
XAEC
EXAMINER'S AMENDMENT ENTERED
02/23/2024
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
02/23/2024
GNEA
EXAMINERS AMENDMENT E-MAILED
02/23/2024
CNEA
EXAMINERS AMENDMENT -WRITTEN
02/23/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
02/13/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
02/13/2024
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
02/13/2024
RFNT
REFUSAL PROCESSED BY IB
10/17/2023
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
09/27/2023
RFRR
REFUSAL PROCESSED BY MPU
09/27/2023
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
09/11/2023
CNRT
NON-FINAL ACTION WRITTEN
09/10/2023
DOCK
ASSIGNED TO EXAMINER
09/03/2023
MAFR
APPLICATION FILING RECEIPT MAILED
02/22/2023
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
02/18/2023
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
02/16/2023
Continuous trademark protection
Get notified about every new filing that threatens INTO ACCELERATING INHALATION DEVELOPMENT or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.